
Verrica Pharmaceuticals Inc
NASDAQ:VRCA

Intrinsic Value
The intrinsic value of one
VRCA
stock under the Base Case scenario is
1.1584
USD.
Compared to the current market price of 0.4654 USD,
Verrica Pharmaceuticals Inc
is
Undervalued by 60%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Verrica Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Verrica Pharmaceuticals Inc
Balance Sheet Decomposition
Verrica Pharmaceuticals Inc
Current Assets | 51.2m |
Cash & Short-Term Investments | 46.3m |
Receivables | 77k |
Other Current Assets | 4.8m |
Non-Current Assets | 3m |
PP&E | 2.6m |
Other Non-Current Assets | 376k |
Free Cash Flow Analysis
Verrica Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Verrica Pharmaceuticals Inc
Revenue
|
7.6m
USD
|
Cost of Revenue
|
-2.7m
USD
|
Gross Profit
|
4.8m
USD
|
Operating Expenses
|
-70.7m
USD
|
Operating Income
|
-65.8m
USD
|
Other Expenses
|
-10.7m
USD
|
Net Income
|
-76.6m
USD
|
VRCA Profitability Score
Profitability Due Diligence
Verrica Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Score
Verrica Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
VRCA Solvency Score
Solvency Due Diligence
Verrica Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Score
Verrica Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VRCA Price Targets Summary
Verrica Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
VRCA
is 3.4 USD
with a low forecast of 2.02 USD and a high forecast of 5.25 USD.
Dividends
Current shareholder yield for VRCA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VRCA
stock under the Base Case scenario is
1.1584
USD.
Compared to the current market price of 0.4654 USD,
Verrica Pharmaceuticals Inc
is
Undervalued by 60%.